151. An artificial intelligence-assisted clinical framework to facilitate diagnostics and translational discovery in hematologic neoplasiaResearch in context
- Author
-
Ming Tang, Željko Antić, Pedram Fardzadeh, Stefan Pietzsch, Charlotte Schröder, Adrian Eberhardt, Alena van Bömmel, Gabriele Escherich, Winfried Hofmann, Martin A. Horstmann, Thomas Illig, J. Matt McCrary, Jana Lentes, Markus Metzler, Wolfgang Nejdl, Brigitte Schlegelberger, Martin Schrappe, Martin Zimmermann, Karolina Miarka-Walczyk, Agata Patsorczak, Gunnar Cario, Bernhard Y. Renard, Martin Stanulla, and Anke Katharina Bergmann
- Subjects
Clinical framework ,Data integration ,Machine learning ,Leukaemia ,Medicine ,Medicine (General) ,R5-920 - Abstract
Summary: Background: The increasing volume and intricacy of sequencing data, along with other clinical and diagnostic data, like drug responses and measurable residual disease, creates challenges for efficient clinical comprehension and interpretation. Using paediatric B-cell precursor acute lymphoblastic leukaemia (BCP-ALL) as a use case, we present an artificial intelligence (AI)-assisted clinical framework clinALL that integrates genomic and clinical data into a user-friendly interface to support routine diagnostics and reveal translational insights for hematologic neoplasia. Methods: We performed targeted RNA sequencing in 1365 cases with haematological neoplasms, primarily paediatric B-cell precursor acute lymphoblastic leukaemia (BCP-ALL) from the AIEOP-BFM ALL study. We carried out fluorescence in situ hybridization (FISH), karyotyping and arrayCGH as part of the routine diagnostics. The analysis results of these assays as well as additional clinical information were integrated into an interactive web interface using Bokeh, where the main graph is based on Uniform Manifold Approximation and Projection (UMAP) analysis of the gene expression data. At the backend of the clinALL, we built both shallow machine learning models and a deep neural network using Scikit-learn and PyTorch respectively. Findings: By applying clinALL, 78% of undetermined patients under the current diagnostic protocol were stratified, and ambiguous cases were investigated. Translational insights were discovered, including IKZF1plus status dependent subpopulations of BCR::ABL1 positive patients, and a subpopulation within ETV6::RUNX1 positive patients that has a high relapse frequency. Our best machine learning models, LDA and PASNET-like neural network models, achieve F1 scores above 97% in predicting patients’ subgroups. Interpretation: An AI-assisted clinical framework that integrates both genomic and clinical data can take full advantage of the available data, improve point-of-care decision-making and reveal clinically relevant insights promptly. Such a lightweight and easily transferable framework works for both whole transcriptome data as well as the cost-effective targeted RNA-seq, enabling efficient and equitable delivery of personalized medicine in small clinics in developing countries. Funding: German Ministry of Education and Research (BMBF), German Research Foundation (DFG) and Foundation for Polish Science.
- Published
- 2024
- Full Text
- View/download PDF